Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -113,056 | -167,870 | -124,776 | -110,319 | -66,448 |
| Depreciation Amortization | 963 | 5,748 | 4,575 | 3,000 | 1,584 |
| Accounts receivable | 1,653 | -16,119 | -12,449 | -3,120 | -8,585 |
| Accounts payable and accrued liabilities | 3,892 | -1,617 | -771 | 572 | 356 |
| Other Working Capital | 21,140 | -24,824 | -32,368 | -13,023 | -8,324 |
| Other Operating Activity | 9,079 | 79,022 | 63,249 | 37,414 | 21,268 |
| Operating Cash Flow | $-76,329 | $-125,660 | $-102,540 | $-85,476 | $-60,149 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | -69,980 | -141,530 | 14,791 | 31,953 |
| PPE Investments | N/A | -1,122 | -1,121 | -1,121 | -1,076 |
| Sale Of Investment | 131,345 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $131,345 | $-71,102 | $-142,651 | $13,670 | $30,877 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,467 | 18,162 | 13,797 | 12,731 | 7,726 |
| Financing Cash Flow | $2,467 | $18,162 | $13,797 | $12,731 | $7,726 |
| Exchange Rate Effect | 2 | 7 | 6 | 3 | 5 |
| Beginning Cash Position | 153,205 | 331,798 | 331,798 | 331,798 | 331,798 |
| End Cash Position | 210,690 | 153,205 | 100,410 | 272,726 | 310,257 |
| Net Cash Flow | $57,485 | $-178,593 | $-231,388 | $-59,072 | $-21,541 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,329 | -125,660 | -102,540 | -85,476 | -60,149 |
| Capital Expenditure | N/A | -1,122 | -1,121 | -1,121 | -1,076 |
| Free Cash Flow | -76,329 | -126,782 | -103,661 | -86,597 | -61,225 |